[Skip to Content]
[Skip to Content Landing]

Applying Lessons Learned From Low-Resource Settings to Prioritize Cancer Care in a Pandemic

Educational Objective
To understand how to prioritize cancer care during a pandemic and in a low-resources settings
1 Credit CME
Abstract

Importance  The coronavirus disease 2019 (COVID-19) pandemic has forced oncology clinicians and administrators in the United States to set priorities for cancer care owing to resource constraints. As oncology practices adapt to a contracted health care system, expertise gained from partnerships in low-resource settings can be used for guidance. This article provides a primer on priority setting in oncology and ethical guidance based on lessons learned from experience with cancer care priority setting in low-resource settings.

Observations  Lessons learned from real-world experiences are myriad. First, in the setting of limited resources, a utilitarian approach to maximizing survival benefit should guide decision-making. Second, conflicting principles will often arise among stakeholders and decision makers. Third, fair decision-making procedures should be established to ensure moral legitimacy and accountability. Fourth, proactive safeguards must be implemented to protect vulnerable individuals, or disparities in cancer treatment and outcomes will only widen further. Fifth, communication with patients and families about priority setting decisions should be intentional and standardized. Sixth, moral distress among clinicians must be addressed to avoid burnout during a time when resilience is critical.

Conclusions and Relevance  Although the need to triage cancer care may be new to those who underwent training and now practice oncology in high-resource settings, it is familiar for those who practice in low- and middle-income countries. Oncologists in the United States facing unprecedented decisions about prioritization can draw on ethical frameworks and lessons learned from real-world cancer care priority setting in resource-constrained environments.

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

Article Information

Accepted for Publication: May 7, 2020.

Published Online: August 6, 2020. doi:10.1001/jamaoncol.2020.2976

Correction: This article was corrected on September 10, 2010, for a misspelled word in the title.

Corresponding Author: Rebecca J. DeBoer, MD, MA, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, 505 Parnassus Ave, M1286, San Francisco, CA 94143-1270 (rebecca.deboer@ucsf.edu).

Author Contributions: Dr DeBoer had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: DeBoer, Shulman, Van Loon.

Acquisition, analysis, or interpretation of data: DeBoer, Fadelu.

Drafting of the manuscript: DeBoer, Van Loon.

Critical revision of the manuscript for important intellectual content: All authors.

Supervision: Shulman, Van Loon.

Conflict of Interest Disclosures: None reported.

Funding/Support: The research referenced in this article is supported by a “Making a Difference in Real-World Bioethics Dilemmas” grant from the Greenwall Foundation. Dr DeBoer was supported by the National Cancer Institute, the Fogarty International Center under Award D43TW009343, the Global Cancer Program at UCSF Helen Diller Family Comprehensive Cancer Center, and the University of California Global Health Institute (UCGHI).

Role of the Funder/Sponsor: The funding sources were not involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.

Disclaimer: The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding sources.

References
1.
Emanuel  EJ , Persad  G , Upshur  R ,  et al.  Fair allocation of scarce medical resources in the time of COVID-19.   N Engl J Med. 2020;382(21):2049-2055. doi:10.1056/NEJMsb2005114PubMedGoogle Scholar
2.
White  DB , Lo  B .  A framework for rationing ventilators and critical care beds during the COVID-19 pandemic.   JAMA. Published online March 27, 2020. doi:10.1001/jama.2020.5046 PubMedGoogle Scholar
3.
Hanna  TP , Evans  GA , Booth  CM .  Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic.   Nat Rev Clin Oncol. 2020;17(5):268-270. doi:10.1038/s41571-020-0362-6 PubMedGoogle Scholar
4.
Schrag  D , Hershman  DL , Basch  E .  Oncology practice during the COVID-19 pandemic.   JAMA. Published online April 13, 2020. doi:10.1001/jama.2020.6236PubMedGoogle Scholar
5.
van de Haar  J , Hoes  LR , Coles  CE ,  et al.  Caring for patients with cancer in the COVID-19 era.   Nat Med. 2020;26(5):665-671. doi:10.1038/s41591-020-0874-8PubMedGoogle Scholar
6.
National Comprehensive Cancer Network. Coronavirus disease 2019 (COVID-19) resources for the cancer care community. Accessed May 1, 2020. https://www.nccn.org/covid-19/default.aspx
7.
Yu  J , Ouyang  W , Chua  MLK , Xie  C .  SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China.   JAMA Oncol. 2020. Published online March 25, 2020. doi:10.1001/jamaoncol.2020.0980 PubMedGoogle Scholar
8.
Liang  W , Guan  W , Chen  R ,  et al.  Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.   Lancet Oncol. 2020;21(3):335-337. doi:10.1016/S1470-2045(20)30096-6 PubMedGoogle Scholar
9.
Marron  JM , Joffe  S , Jagsi  R , Spence  RA , Hlubocky  FJ .  Ethics and resource scarcity: ASCO recommendations for the oncology community during the COVID-19 pandemic.   J Clin Oncol. 2020;38(19):2201-2205. Published online April 28, 2020. doi:10.1200/JCO.20.00960PubMedGoogle Scholar
10.
Emanuel  E , Schmidt  H , Steinmetz  A .  Rationing and Resource Allocation in Healthcare: Essential Readings. Oxford University Press; 2018.
11.
Biddison  ELD , Gwon  HS , Schoch-Spana  M ,  et al.  Scarce resource allocation during disasters: a mixed-method community engagement study.   Chest. 2018;153(1):187-195. doi:10.1016/j.chest.2017.08.001 PubMedGoogle Scholar
12.
Schnipper  LE , Davidson  NE , Wollins  DS ,  et al; American Society of Clinical Oncology.  American Society of Clinical Oncology statement: a conceptual framework to assess the value of cancer treatment options.   J Clin Oncol. 2015;33(23):2563-2577. doi:10.1200/JCO.2015.61.6706 PubMedGoogle Scholar
13.
Schnipper  LE , Davidson  NE , Wollins  DS ,  et al.  Updating the American Society of Clinical Oncology value framework: revisions and reflections in response to comments received.   J Clin Oncol. 2016;34(24):2925-2934. doi:10.1200/JCO.2016.68.2518 PubMedGoogle Scholar
14.
Cherny  NI , Sullivan  R , Dafni  U ,  et al.  A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS).   Ann Oncol. 2015;26(8):1547-1573. doi:10.1093/annonc/mdv249 PubMedGoogle Scholar
15.
Cherny  NI , Dafni  U , Bogaerts  J ,  et al.  ESMO-Magnitude of Clinical Benefit Scale version 1.1.   Ann Oncol. 2017;28(10):2340-2366. doi:10.1093/annonc/mdx310 PubMedGoogle Scholar
16.
Aggarwal  A , Ginsburg  O , Fojo  T .  Cancer economics, policy and politics: what informs the debate? perspectives from the EU, Canada and US.   J Cancer Policy. 2014;2(1):1-11. doi:10.1016/j.jcpo.2014.02.002 Google Scholar
17.
Morgan  SG , McMahon  M , Mitton  C ,  et al.  Centralized drug review processes in Australia, Canada, New Zealand, and the United Kingdom.   Health Aff (Millwood). 2006;25(2):337-347. doi:10.1377/hlthaff.25.2.337 PubMedGoogle Scholar
18.
Lim  KSH , Vinod  SK , Bull  C , O’Brien  P , Kenny  L .  Prioritization of radiotherapy in Australia and New Zealand.   Australas Radiol. 2005;49(6):485-488. doi:10.1111/j.1440-1673.2005.01391.x PubMedGoogle Scholar
19.
Jagsi  R , DeLaney  TF , Donelan  K , Tarbell  NJ .  Real-time rationing of scarce resources: the Northeast Proton Therapy Center experience.   J Clin Oncol. 2004;22(11):2246-2250. doi:10.1200/JCO.2004.10.083 PubMedGoogle Scholar
20.
Jagsi  R , Spence  R , Rathmell  WK ,  et al.  Ethical considerations for the clinical oncologist in an era of oncology drug shortages.   Oncologist. 2014;19(2):186-192. doi:10.1634/theoncologist.2013-0301 PubMedGoogle Scholar
21.
Hantel  A .  A protocol and ethical framework for the distribution of rationed chemotherapy.   J Clin Ethics. 2014;25(2):102-115.PubMedGoogle Scholar
22.
Unguru  Y , Fernandez  CV , Bernhardt  B ,  et al.  An ethical framework for allocating scarce life-saving chemotherapy and supportive care drugs for childhood cancer.   J Natl Cancer Inst. 2016;108(6):djv392. doi:10.1093/jnci/djv392 PubMedGoogle Scholar
23.
Hantel  A , Abel  GA , Siegler  M .  Practical allocation system for the distribution of specialised care during cellular therapy access scarcity.   J Med Ethics. 2019;45(8):532-537. doi:10.1136/medethics-2018-105339 PubMedGoogle Scholar
24.
Binagwaho  A , Farmer  PE , Nsanzimana  S ,  et al.  Rwanda 20 years on: investing in life.   Lancet. 2014;384(9940):371-375. doi:10.1016/S0140-6736(14)60574-2 PubMedGoogle Scholar
25.
Stulac  S , Binagwaho  A , Tapela  NM ,  et al.  Capacity building for oncology programmes in sub-Saharan Africa: the Rwanda experience.   Lancet Oncol. 2015;16(8):e405-e413. doi:10.1016/S1470-2045(15)00161-8 PubMedGoogle Scholar
26.
Ocean Road Cancer Institute. Historical background. Accessed September 5, 2017. https://www.orci.or.tz/historical-background/
27.
International Monetary Fund, African Department.  Regional Economic Outlook: Sub-Saharan Africa: Navigating Uncertainty. International Monetary Fund; 2020.
28.
Shulman  LN , Wagner  CM , Barr  R ,  et al.  Proposing essential medicines to treat cancer: methodologies, processes, and outcomes.   J Clin Oncol. 2016;34(1):69-75. doi:10.1200/JCO.2015.61.8736 PubMedGoogle Scholar
29.
Anderson  BO , Shyyan  R , Eniu  A ,  et al.  Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines.   Breast J. 2006;12(suppl 1):S3-S15. doi:10.1111/j.1075-122X.2006.00199.x PubMedGoogle Scholar
30.
Chuang  LT , Temin  S , Camacho  R ,  et al.  Management and care of women with invasive cervical cancer: American Society of Clinical Oncology resource-stratified clinical practice guideline.   J Glob Oncol. 2016;2(5):311-340. doi:10.1200/JGO.2016.003954 PubMedGoogle Scholar
31.
Carlson  RW , Scavone  JL , Koh  W-J ,  et al.  NCCN framework for resource stratification: a framework for providing and improving global quality oncology care.   J Natl Compr Canc Netw. 2016;14(8):961-969. doi:10.6004/jnccn.2016.0103 PubMedGoogle Scholar
32.
Porter  ME .  What is value in health care?   N Engl J Med. 2010;363(26):2477-2481. doi:10.1056/NEJMp1011024 PubMedGoogle Scholar
33.
Shyirambere  C , DeBoer  RJ , Bigirimana  JB ,  et al. Development of radiotherapy prioritization guidelines at Butaro Hospital in Rwanda. Paper presented at: African Organization for Research and Training in Cancer (AORTIC); November 2019; Maputo, Mozambique.
34.
DeBoer  RJ , Nguyen  C , Shyirambere  C ,  et al. Experience and views of providers and program leaders engaged in patient prioritization for radiotherapy in Rwanda. Paper presented at: African Organization for Research and Training in Cancer (AORTIC); November 2019; Maputo, Mozambique.
35.
Persad  G , Wertheimer  A , Emanuel  EJ .  Principles for allocation of scarce medical interventions.   Lancet. 2009;373(9661):423-431. doi:10.1016/S0140-6736(09)60137-9 PubMedGoogle Scholar
36.
Miller  FG . Why I support age-related rationing of ventilators for COVID-19 patients. The Hastings Center. Published April 9, 2020. Accessed May 2, 2020. https://www.thehastingscenter.org/why-i-support-age-related-rationing-of-ventilators-for-covid-19-patients/
37.
Aronson  L . “Covid-19 kills only old people.” only? New York Times. Published March 22, 2020. Accessed May 2, 2020. https://www.nytimes.com/2020/03/22/opinion/coronavirus-elderly.html
38.
Daniels  N .  Decisions about access to health care and accountability for reasonableness.   J Urban Health. 1999;76(2):176-191. doi:10.1007/BF02344674 PubMedGoogle Scholar
39.
Carrera  PM , Kantarjian  HM , Blinder  VS .  The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatment.   CA Cancer J Clin. 2018;68(2):153-165. doi:10.3322/caac.21443 PubMedGoogle Scholar
40.
Bibbins-Domingo  K .  This time must be different: disparities during the COVID-19 pandemic.   Ann Intern Med. Published online April 28, 2020. doi:10.7326/M20-2247PubMedGoogle Scholar
41.
Benfer  EA , Wiley  LF . Health justice strategies to combat COVID-19: protecting vulnerable communities during a pandemic. Health Affairs. Published March 19, 2020. Accessed March 28, 2020. https://www.healthaffairs.org/do/10.1377/hblog20200319.757883/full/
42.
American Society of Clinical Oncology. COVID-19 provider & practice information. Published March 18, 2020. Accessed March 23, 2020. https://www.asco.org/asco-coronavirus-information/provider-practice-preparedness-covid-19
43.
Nouri  S , Khoong  EC , Lyles  CR , Karliner  L . Addressing equity in telemedicine for chronic disease management during the COVID-19 pandemic. NEJM Catalyst. Published May 4, 2020:13. Accessed June 25, 2020. https://catalyst.nejm.org/doi/full/10.1056/CAT.20.0123
44.
Bernacki  RE , Block  SD ; American College of Physicians High Value Care Task Force.  Communication about serious illness care goals: a review and synthesis of best practices.   JAMA Intern Med. 2014;174(12):1994-2003. doi:10.1001/jamainternmed.2014.5271 PubMedGoogle Scholar
45.
Mack  JW , Cronin  A , Keating  NL ,  et al.  Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study.   J Clin Oncol. 2012;30(35):4387-4395. doi:10.1200/JCO.2012.43.6055 PubMedGoogle Scholar
46.
VitalTalk. COVID ready communication playbook. Accessed March 26, 2020. https://www.vitaltalk.org/guides/covid-19-communication-skills/
47.
Jameton  A .  Nursing Practice: The Ethical Issues. Prentice-Hall; 1984.
48.
Harrison  KL , Dzeng  E , Ritchie  CS ,  et al.  Addressing palliative care clinician burnout in organizations: a workforce necessity, an ethical imperative.   J Pain Symptom Manage. 2017;53(6):1091-1096. doi:10.1016/j.jpainsymman.2017.01.007 PubMedGoogle Scholar
49.
Maruthappu  M , Watkins  J , Noor  AM ,  et al.  Economic downturns, universal health coverage, and cancer mortality in high-income and middle-income countries, 1990-2010: a longitudinal analysis.   Lancet. 2016;388(10045):684-695. doi:10.1016/S0140-6736(16)00577-8 PubMedGoogle Scholar
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_LoginSubscribe_Purchase
Close
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_LoginSubscribe_Purchase
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
Close
With a personal account, you can:
  • Track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
jn-learning_Modal_SaveSearch_NoAccess_Purchase
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close